Adityanjee, EstereraAB. Successful treatment of tardive dystonia with clozapine. Biol Psychiatry, 39:1064–1065. 1996.
2.
American Psychiatic Association. Diagnostic and Statistical Manual of Mental Disorders, 4thText Revision (DSM-IV-TR)Washington, DC: American Psychiatric Association, 2000.
3.
BassittDP, NetoMRL. Clozapine efficacy in tardive dyskinesia in schizophrenic patients. Eur Arch Psychiatry Clin Neurosci, 248:209–211. 1998.
4.
BurkeRE, FahnS, JankovicJ, MarsdenD, LangA, GollompS, IlsonJ. Tardive dystonia: Late onset and persistent dystonia caused by antipsychotic drugs. Neurology, 32:1335–1346. 1982.
5.
ChatterjeeA, Forrest GordonM, GiladiN, TroschR. Botulinum toxin in the treatment of tardive dystonia. J Clin Psychopharmacol, 17:497–498. 1997.
6.
ConnorD, McLaughlinT, Jeffers-TerryM. Randomized controlled pilot study of quetiapine in the treatment of adolescent conduct disorder. J Child Adolesc Psychopharmacol, 18:140–156. 2008.
7.
ConusP, ZullinoD, BaumannP. Clozapine is more efficacious for tongue dystonia than olanzapine. Psychopharmacology, 162:89. 2002.
8.
CorrellC, KaneJ. One year incidence rates of tardive dyskinesia in children and adolescents treated with second generation antipsychotics: A systematic review. J Child Adolesc Psychopharmacol, 17:647–655. 2007.
9.
DelBelloM, ChangK, WelgeJ, AdlerC, RanaM, HoweM, BryanH, VogelD, SampangS, DelgadoS, StrakowskiS. A double-blind, placebo-controlled pilot study of quetiapine for depressed adolescents with bipolar disorder. Bipolar disord, 11:483–493. 2009.
10.
DelBelloM, SchwiersM, RosenbergL, StrakowskiS. A double-blind, randomized, placebo-controlled study of quetiapine as adjunctive treatment for adolescent mania. J Am Acad Child Adolesc Psychiatry, 41:1216–1223. 2002.
11.
DresslerD, OeljeschlagerRO, RutherE. Severe tardive dystonia: Treatment with continuous intrathecal baclofen administration. Mov Disord, 12:585–587. 1997.
12.
FranziniA, MarrasC, FerroliP, ZorziG, BugianiO, RomitoL, BroggiC. Long term high frequency bilateral pallidal stimulation for neuroleptic induced tardive dystonia. Report of two cases. J Neurosurgery, 102:721–725. 2005.
13.
FriedmanJH. Clozapine treatment of psychosis in patients with tardive dystonia: Report of three cases. Mov Disord, 9:321–324. 1994.
14.
JankovicJ, BeachJ. Long term effects of tetrabenazine in hyperkinetic movement disorders. Neurology, 48:358–362. 1997.
PringsheimT, LamD, ChingH, PattenP. Metabolic, neurological complications of second generation antipsychotic use in children: A systematic review, meta-analysis of randomized controlled trialsIn press.
20.
RosseRB, AllenA, LuxWE. Baclofen treatment in a patient with tardive dystonia. J Clin Psychiatry, 47:474–475. 1986.
21.
SalleeF, KurlanR, GoetzC, SignerH, ScahillL, LawG, DittmanV, ChappellP. Ziprasidone treatment of children and adolescents with tourette's syndrome: A pilot study. J Am Acad Child Adolesc Psychiatry, 39:292–299. 2000.
SikichL, FrazierJ, McClellanJ, FindlingRL, VitielloB, RitzL, AmblerD, PugliaM, MaloneyAE, MichaelE, De JongS, SlifkaK, NoyesN, HlastalaS, PiersonL, McNamaraNK, Delporto-BedoyaD, AndersonR, HamerRM, LiebermanJA. Double-blind comparison of first- and second-generation antipsychotics in early-onset schizophrenia and schizoaffective disorder: Findings from the Treatment of Early-onset Schizophrenia Spectrum Disorders (TEOSS) Study. Am J Psychiatry, 165:1420–1431. 2008.
24.
SikichL, HamerR, BashfordR, SheitmanBB, LiebermanJA. A pilot study of risperidone, olanzapine, and haloperidol in psychotic youth: A double-blind, randomized, 8-week trial. Neuropsychopharmacology, 29:133–145. 2004.
25.
WonodiI, ReevesG, CarmichaelD, VerovskyI, AvilaMT, ElliottA, HongLE, AdamiHM, ThakerGK. Tardive dyskinesia in children treated with atypical antipsychotic medications. Mov Disord, 22:1777–1782. 2007.